- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06691763
Pythagorean Self-Awareness Intervention on Psoriasis Patients. (PSAIPSORIASI)
November 14, 2024 updated by: Christina Darviri, National and Kapodistrian University of Athens
The Effect of Pythagorean Self-Awareness Technique on Patients with Psoriasis. the Alternations in Hair Cortisol Levels Via Affecting Hypothalamic-Pituitary-Adrenal Axis.
This one-arm, pilot, non-randomized, study was conducted at the Specialized Psoriasis Unit of Andreas Syggros Hospital in Athens, Greece.
All participants were informed about the objectives and procedures of the study, and written informed consent was provided prior to participation.
The study protocol was approved by the hospital's Scientific and Ethics Committee (protocol number: 472 /07-12-2023)and was in accordance with the Declaration of Helsinki.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Pythagorean Self-Awareness Intervention (PSAI) to a sample of psoriasis patients.
Primary aim was the reduction of perceived stress levels.
Secondary aims were the enhancement of stress response (HRV), increase cortisol levels, improvement of sleep quality, adoption of healthy behaviors, emotional regulation (e.g., shame and anger), cognitive performance enhancement (e.g., visual-spatial memory, verbal learning, information processing speed), as well as improvements in body composition indices (e.g., weight, body mass index (BMI), intermuscular adipose tissue (IMAT), fat mass, and free fat mass).
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Athens, Greece, 161 21
- Andreas Syggros Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Confirmed diagnosis of psoriasis
- Speaking and writing in Greek language
Exclusion Criteria:
- Use of oral corticosteroids
- Diagnosis of any serious mental disorder
- Drug addictions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Pretest T0
Usual care
|
|
|
No Intervention: Pretest T1
Usual care
|
|
|
Experimental: Post-test T2
PSAI
|
Pythagorean Self-Awareness is a holistic stress magement program that combines cognitive reconstruction and the implementation of the 6 pillars of life-style medicine depending on the targeted population.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale (PSS-14)
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurements
|
To assess perceived stress, the Greek version of the PSS questionnaire was administered, which consists of 14 items, each graded on a 5-point Likert scale.
More specifically, there are seven positive and seven negative items and the total score ranges from 0 to 56.
Higher PSS scores indicate higher levels of perceived in the past month.
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurements
|
|
Hair cortisol
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
Hair samples were collected from each participant twice prior to the intervention and once following the intervention.
The samples were taken from the posterior vertex of the scalp.
Cortisol levels were analyzed retrospectively by examining the hair segments.
The proximal 1 cm segment closest to the scalp reflects cortisol secretion over the past month, while the second most proximal 1 cm segment represents cortisol production from the preceding month, and so on.
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate Variability
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
To collect HRV data via ECG, we utilized the NeXus hardware in combination with the BioTrace+ software (NeXus-10 version 2023; BioTrace+, Mind Media, Herten, the Netherlands).
The NeXus system integrates HRV-BF with psychophysiological research and offers ECG data in both time and frequency domains using self-adhesive electrodes.
The researcher manually initiated NeXus measurements at the start of the PPG data collection to ensure simultaneous acquisition of both PPG and ECG data.
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
|
Pittsburgh Sleep Quality Index
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
Sleep quality was assessed using the Greek version of the PSQI questionnaire.
The PSQI consists of 19 self-report questions, grouped into 7 components (subjective sense of sleep quality, awakening time, latent period, duration, usual sleep productivity, use of sleep medication and daytime dysfunction).
The score ranges from 0 to 3, resulting in a total score ranging from 0=high sleep quality to 21=low sleep quality.
A total score of > or = 5 indicates poor sleep
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
|
Healthy Life-style and Personal Control Questionnaire
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
The healthy lifestyle and self-monitoring questionnaire consists of 26 items, which are divided into a 4-point Likert scale ranging from 1=never/rarely to 4= always.
A higher score indicates increased health empowerment.
Specifically, the HLPCQ is designed to assess one's degree of control over daily activities such as diet, daily schedule, physical activity, socialization and pessimistic thoughts
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
|
Cognitive assessment
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
The standardized battery Brief Intentory for Cognitive Assessment(BICA) was used to assess cognitive functions in the participants.
This memory assessment tool took about 15 minutes to complete is completed and included three categories of cognitive tests: The Normal Symbol Digital Modalities Test (SDMT), which measured information processing speed, the California Verbal Learning Test-II (CVLT-II), which assessed verbal memory and subsequent immediate recall.
Finally, the third test concerned short visuospatial memory Test Revised (BVMTR), which assessed visual memory and immediate recall.
Low scores indicated cognitive dysfunctions and cognitive decline.
The specific tool for memory assessment has been proposed to help practitioners identify a potential cognitive dysfunction in humans.
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
|
Anger evaluation
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
The STAXI questionnaire examines how individuals respond or behave when they feel angry.
The Greek version of the 24-item STAXI was utilized.
The items are rated on a four-point Likert-type scale (1 ¼ almost never to 4 ¼ almost always) three subscales: not expressing anger, expressing anger, controlling anger.
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
|
Shame, Guilt and Pride assessment
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
The State Shame and Guilt Scale is a 15-item self-report questionnaire designed to assess shame, guilt and pride in response to a specific situation.
Participants rate their responses on a 5-point Likert scale, ranging from "I don't feel that way at all" to "I feel very strongly that way".
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
|
Health Locus of Control (HLC)
Time Frame: Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
The HLC scale was employed to assess participants' beliefs regarding their perceived control over their health.
This 18-item scale is divided into three subscales: HLC internal, HLC external, and HLC chance (denoted as HLC-1, HLC-2, and HLC-3, respectively).
The internal HLC subscale measures the extent to which an individual believes they are responsible for their own health and well-being.
The HLC external subscale assesses the degree to which individuals attribute their health to external factors, such as other people or societal influences.
The HLC subscale reflects beliefs that health outcomes are governed by chance or random factors beyond the individual's control.
Higher scores on each subscale indicate a stronger belief in the corresponding type of control (internal, external, or chance) as a determinant of health.
|
Two times before the intervention (with 1 month distance) and 4 months after baseline measurement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Christina Darviri, Professor, Postgraduate Course of Stress Science & Health Promotion, NKUA, Greece
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Charalampopoulou M, Bacopoulou F, Syrigos KN, Filopoulos E, Chrousos GP, Darviri C. The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial. Breast. 2020 Feb;49:210-218. doi: 10.1016/j.breast.2019.12.012. Epub 2019 Dec 20.
- Athanasopoulou S, Simos D, Charalampopoulou M, Tentolouris N, Kokkinos A, Bacopoulou F, Aggelopoulou E, Zigkiri E, Chrousos GP, Darviri C, Gonos ES. Significant improvement of stress and aging biomarkers using a novel stress management program with the cognitive restructuring method "Pythagorean Self-Awareness Intervention" in patients with type 2 diabetes mellitus and healthy adults. Mech Ageing Dev. 2021 Sep;198:111538. doi: 10.1016/j.mad.2021.111538. Epub 2021 Jul 1.
- Panagopoulou Z, Artemiadis AK, Chrousos GP, Darviri C, Anagnostouli MC. Pythagorean Self-Awareness Intervention for Multiple Sclerosis Patients: A Quasi-Experimental Pragmatic Trial. Arch Clin Neuropsychol. 2022 Jan 17;37(1):125-132. doi: 10.1093/arclin/acab044.
- Psarraki EE, Bacopoulou F, Panagoulias E, Michou M, Pelekasis P, Artemiadis A, Chrousos GP, Darviri C. The effects of Pythagorean Self-Awareness Intervention on patients with major depressive disorder: A pilot randomized controlled trial. J Psychiatr Res. 2021 Jun;138:326-334. doi: 10.1016/j.jpsychires.2021.03.067. Epub 2021 Apr 13.
- Gorgili K, Artemiadis A, Bacopoulou F, Karatzas P, Tigani X, Vlachakis D, Kokka I, Varvogli L, Chrousos GP, Darviri C. The Effects of Pythagorean Self-Awareness Intervention on Irritable Bowel Syndrome Patients: A Non-randomized Controlled Trial. Adv Exp Med Biol. 2021;1337:345-354. doi: 10.1007/978-3-030-78771-4_39.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 4, 2023
Primary Completion (Actual)
July 8, 2024
Study Completion (Actual)
September 10, 2024
Study Registration Dates
First Submitted
November 11, 2024
First Submitted That Met QC Criteria
November 14, 2024
First Posted (Actual)
November 15, 2024
Study Record Updates
Last Update Posted (Actual)
November 15, 2024
Last Update Submitted That Met QC Criteria
November 14, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 472 /07-12-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Upon request after publication
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psoriasis
-
ProgenaBiomeWithdrawnPsoriasis | Psoriasis Vulgaris | Psoriasis of Scalp | Psoriatic Plaque | Psoriasis Universalis | Psoriasis Face | Psoriasis Nail | Psoriasis Diffusa | Psoriasis Punctata | Psoriasis Palmaris | Psoriasis Circinata | Psoriasis Annularis | Psoriasis Genital | Psoriasis GeographicaUnited States
-
Clin4allActive, not recruitingPsoriasis of Scalp | Psoriasis Nail | Psoriasis Palmaris | Psoriasis Genital | Psoriasis PlantarisFrance
-
Alumis IncActive, not recruitingPsoriasis | Plaque Psoriasis | Psoriasis (PsO) | Moderate Psoriasis | Severe PsoriasisUnited States, Canada, Australia, Germany, Spain, Hungary, Japan, Bulgaria, Poland, Czechia, Estonia, Latvia, Puerto Rico, Portugal, South Korea, France
-
Innovaderm Research Inc.CompletedScalp Psoriasis | Pustular Palmo-plantar Psoriasis | Non-pustular Palmo-plantar Psoriasis | Elbow Psoriasis | Lower Leg PsoriasisCanada
-
Caja Costarricense de Seguro SocialNot yet recruitingPsoriasis | Psoriasis (PsO) | Psoriasis Arthritis | Psoriasis PatientsCosta Rica
-
Centre of Evidence of the French Society of DermatologyRecruitingPsoriasis | Psoriasis Vulgaris | Psoriasis of Scalp | Psoriatic Plaque | Psoriasis Universalis | Psoriasis Palmaris | Psoriatic Erythroderma | Psoriatic Nail | Psoriasis Guttate | Psoriasis Inverse | Psoriasis PustularFrance
-
AmgenCompletedPsoriasis-Type Psoriasis | Plaque-Type PsoriasisUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate to Severe Psoriasis | Generalized Pustular Psoriasis and Erythrodermic PsoriasisJapan
-
Janssen Pharmaceutical K.K.Active, not recruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
Eli Lilly and CompanyCompletedGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
Clinical Trials on Pythagorean Self-Awareness Intervention for stress management and health promotion
-
Harokopio UniversityUniversity of Thessaly; University of Ioannina; University of Patras; CitiesNet; ... and other collaboratorsRecruiting
-
Maria CharalampopoulouHippocration General Hospital; Saint Savvas Anticancer Hospital; Hellenic Anticancer...CompletedBreast Cancer | Stress | Telomere Length, Mean LeukocyteGreece
-
Parc de Salut MarInstituto de Salud Carlos IIICompletedDepression | Suicide, Attempted | SuicideSpain
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHypertension | Cardiovascular Disease | Diabetes | HIV | Colon CancerUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
VA Office of Research and DevelopmentRecruitingAlcohol-Related Disorders | Tobacco SmokingUnited States
-
Huzhou UniversityCompletedHealth Promotion Behavior | Elderly MigrantsChina
-
Bartın UnıversityNot yet recruitingHypertension | High Blood Pressure
-
Universiti Teknologi MaraMinistry of Education, MalaysiaNot yet recruitingMetabolic Syndrome
-
The Hong Kong Polytechnic UniversityRecruitingKnee Osteoarthritis (Knee OA)Hong Kong